These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Nevada
|
26-2797630
|
|
|
(State or jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|
|
6460 Medical Center St. Suite 230
Las Vegas, NV
|
89148
|
|
|
(Address of principal executive offices)
|
(Zip code)
|
|
Large Accelerated Filer
|
£
|
Accelerated Filer
|
£
|
|
|
Non-Accelerated Filer
|
£
|
Smaller Reporting Company
|
T
|
|
Page
|
|
|
PART I - FINANCIAL INFORMATION
|
|
|
ITEM 1. FINANCIAL STATEMENTS
|
3
|
|
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
8 |
|
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
11
|
|
ITEM 4A (T). CONTROLS AND PROCEDURES
|
11
|
|
PART II - OTHER INFORMATION
|
|
|
ITEM 1. LEGAL PROCEEDINGS
|
13
|
|
ITEM 1A. RISK FACTORS
|
13
|
|
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
13
|
|
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
|
13
|
|
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
13
|
|
ITEM 5. OTHER INFORMATION
|
13
|
|
ITEM 6. EXHIBITS
|
14
|
|
SIGNATURES
|
15
|
|
March 31,
|
December 31,
|
|||||||
|
2014
|
2013
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash
|
$ | 53,638 | $ | 20,689 | ||||
|
Accounts receivable
|
119,156 | 58,328 | ||||||
|
Inventory
|
14,114 | 14,114 | ||||||
|
Total current assets
|
186,908 | 93,131 | ||||||
|
Property and Equipment, Net
|
150,759 | 165,306 | ||||||
|
Total assets
|
337,667 | 258,437 | ||||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 67,109 | $ | 34,112 | ||||
|
10% Series A Senior (non-subordinated) debentures
|
5,000 | 5,000 | ||||||
|
Accrued interest
|
17,326 | 15,376 | ||||||
|
Customer deposits
|
- | 12,501 | ||||||
|
Loan payable, current
|
25,000 | 25,000 | ||||||
|
Notes Payable-related parties
|
85,000 | 91,000 | ||||||
|
Total current liabilities
|
199,435 | 182,989 | ||||||
|
Total liabilities
|
199,435 | 182,989 | ||||||
|
STOCKHOLDERS' EQUITY
|
||||||||
|
Common stock: $0.001 par value; 300,000,000 authorized, 190,356,131 and 193,856,138 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively
|
190,356 | 193,856 | ||||||
|
Preferred stock: $1.00 par value; 500,000 authorized, 440,500 and 440,500 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively
|
441 | 441 | ||||||
|
Additional paid in capital
|
9,623,666 | 9,620,166 | ||||||
|
Accumulated deficit
|
(9,676,231 | ) | (9,739,015 | ) | ||||
|
Total stockholders' equity
|
138,232 | 75,448 | ||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$ | 337,667 | $ | 258,437 | ||||
|
For the Three Months Ended
|
||||||||
|
March 31,
|
March 31,
|
|||||||
|
2014
|
2013
|
|||||||
|
REVENUES
|
$ | 208,356 | $ | 114,298 | ||||
|
Cost of goods sold
|
54,198 | 10,383 | ||||||
|
Gross Profit
|
154,158 | 103,915 | ||||||
|
General, selling and administrative expenses
|
88,401 | 1,076,875 | ||||||
|
Total operating expenses
|
88,401 | 1,076,875 | ||||||
|
Operating Income (Loss)
|
65,757 | (972,960 | ) | |||||
|
Other income (expense):
|
||||||||
|
Other income
|
348 | - | ||||||
|
Interest expense
|
(3,321 | ) | (1,085 | ) | ||||
|
Total other (expense)
|
(2,973 | ) | (1,085 | ) | ||||
|
Net Income (Loss)
|
$ | 62,784 | $ | (974,045 | ) | |||
|
Net Income (loss) per common share - basic and diluted
|
$ | 0.00 | $ | (0.01 | ) | |||
|
Weighted average of common shares outstanding
|
191,250,577 | 170,569,128 | ||||||
|
For the Three Months Ended
|
||||||||
|
March 31,
|
March 31,
|
|||||||
|
2014
|
2013
|
|||||||
|
Cash Flows From Operating Activities:
|
||||||||
|
Net Income (Loss)
|
$ | 62,784 | $ | (974,045 | ) | |||
|
Adjustments to reconcile net income (loss) to net cash provided by operations
|
||||||||
|
Depreciation
|
14,547 | 10,182 | ||||||
|
Stock for services
|
- | 682,495 | ||||||
|
Net assets from discontinued operations
|
- | (15,633 | ) | |||||
|
Changes in assets and liabilities:
|
||||||||
|
(Increase) accounts receivable
|
(60,828 | ) | (22,296 | ) | ||||
|
Decrease prepaid expenses
|
- | 254,600 | ||||||
|
Decrease inventory
|
- | 1,164 | ||||||
|
Increase accounts payable and accrued expenses
|
32,997 | 69,642 | ||||||
|
(Decrease) customer deposits
|
(12,501 | ) | - | |||||
|
Net cash provided by operating activities
|
36,999 | 6,109 | ||||||
|
Cash Flows From Investing Activities:
|
||||||||
|
Capital expenditures
|
- | - | ||||||
|
Net cash used in investing activities
|
- | - | ||||||
|
Cash Flows From Financing Activities:
|
||||||||
|
Accrued interest
|
1,950 | 1,066 | ||||||
|
Repayment of note payable
|
(6,000 | ) | 7,000 | |||||
|
Net cash provided by (used in) financing activities
|
(4,050 | ) | 8,066 | |||||
|
Net increase in cash
|
32,949 | 14,175 | ||||||
|
Cash, beginning of period
|
20,689 | 5,523 | ||||||
|
Cash, end of period
|
$ | 53,638 | $ | 19,698 | ||||
|
Cash paid for:
|
||||||||
|
Interest
|
$ | - | $ | 1,085 | ||||
|
March 31,
|
March 31,
|
|||||||||||||||
|
2014
|
2013
|
$ Change
|
% Change
|
|||||||||||||
|
Revenues
|
$ | 208,356 | $ | 114,298 | $ | 94,058 | 82.29 | % | ||||||||
|
Cost of sales
|
(54,198 | ) | (10,383 | ) | (43,815 | ) | 421.99 | % | ||||||||
|
Gross profit
|
154,158 | 103,915 | 50,243 | 48.35 | % | |||||||||||
|
General and administrative expenses
|
(88,401 | ) | (1,076,875 | ) | 988,474 | -91.79 | % | |||||||||
|
Operating Income (Loss)
|
$ | 65,757 | $ | (972,960 | ) | $ | 1,038,717 | 106.76 | % | |||||||
|
March 31,
|
December 31,
|
|||||||||||||||
|
2014
|
2013
|
$ Change
|
% Change
|
|||||||||||||
|
Cash
|
$ | 53,638 | $ | 20,689 | $ | 32,949 | 159 | % | ||||||||
|
Accounts payable and accrued expenses
|
67,109 | 34,112 | 32,997 | 97 | % | |||||||||||
|
Total current liabilities
|
199,435 | 182,989 | 16,446 | 9 | % | |||||||||||
|
Cash proceeds from the sale of preferred stock
|
$ | - | $ | 3,000 | $ | (3,000 | ) | -100 | % | |||||||
|
|
·
|
Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;
|
|
|
·
|
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.
|
|
Exhibit No.
|
Description
|
|
|
31.1
|
|
Certification of Chief Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
31.2
|
|
Certification of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32.1
|
|
Certification of Chief Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
32.2
|
Certification of Principal Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
Dated: May 14, 2014
|
||
|
By
|
/s/ Dennis Cullison
|
|
|
Dennis Cullison
|
||
|
Chief Executive Officer, President and Director
|
||
|
Dated: May 14, 2014
|
||
|
By
|
/s/ Larry Bonafide
|
|
|
Larry Bonafide
|
||
|
Principle Financial Officer, Secretary and Director
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| The Scotts Miracle-Gro Company | SMG |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|